Literature DB >> 9474230

Role of chronic inflammation in the promotion of prostatic hyperplasia in rats.

O J Kessler1, Y Keisari, C Servadio, A Abramovici.   

Abstract

PURPOSE: Chronic prostatitis is a common histopathological finding in prostatectomized patients. A possible interrelationship between the presence of leukocyte exudate and the extent of the hyperplastic lesions has been suggested. The aim of the present study was to analyze the effect of the immunomodulator compounds, Complete Freund Adjuvant (CFA) and cyclosporin A (CsA), administered alone or together with citral on the induction and extent of rat prostatic hyperplasia.
MATERIALS AND METHODS: Adolescent Wistar rats (42 days old) were given citral alone or combined with CFA or CsA for one month. Semiquantitative analysis of the extent of the hyperplastic lesions was made with the histoscore protocol.
RESULTS: CsA did not induce hyperplastic changes or abolish the ability of citral to promote hyperplastic changes or to affect the extent of the lymphocytic exudate in the stroma. CFA itself, however, had a proliferative action on the prostatic epithelium, and it augmented the hyperplastic changes induced by citral and even induced atypical transformations of the acinar epithelium.
CONCLUSIONS: Immunoinflammatory stimulators might play a role in the prostatic epithelial cell growth and proliferation processes, most probably by modulation of the cytokine system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9474230

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

1.  Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Authors:  Siobhan Sutcliffe; Robert L Grubb Iii; Elizabeth A Platz; Lawrence R Ragard; Thomas L Riley; Sally S Kazin; Richard B Hayes; Ann W Hsing; Gerald L Andriole
Journal:  BJU Int       Date:  2012-03-19       Impact factor: 5.588

2.  Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia.

Authors:  D Altavilla; L Minutoli; F Polito; N Irrera; S Arena; C Magno; M Rinaldi; B P Burnett; F Squadrito; A Bitto
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

3.  Associations between variants in the cyclooxygenase 2 enzyme gene (PTGS2) and development of benign prostate enlargement.

Authors:  Jennifer L St Sauver; Michael M Lieber; Susan L Slager; Debra J Jacobson; Michaela E McGree; Steven J Jacobsen
Journal:  BJU Int       Date:  2011-04-11       Impact factor: 5.588

4.  Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.

Authors:  Jeannette M Schenk; Alan R Kristal; Marian L Neuhouser; Catherine M Tangen; Emily White; Daniel W Lin; Mario Kratz; Ian M Thompson
Journal:  Am J Epidemiol       Date:  2010-02-08       Impact factor: 4.897

5.  Effect of sexually transmitted infections, lifetime sexual partner count, and recreational drug use on lower urinary tract symptoms in men who have sex with men.

Authors:  Benjamin N Breyer; Eric Vittinghoff; Stephen K Van Den Eeden; Bradley A Erickson; Alan W Shindel
Journal:  Urology       Date:  2011-10-02       Impact factor: 2.649

6.  Effects of different natural extracts in an experimental model of benign prostatic hyperplasia (BPH).

Authors:  Irene Paterniti; Michela Campolo; Marika Cordaro; Rosalba Siracusa; Antonio Filippone; Emanuela Esposito; Salvatore Cuzzocrea
Journal:  Inflamm Res       Date:  2018-04-20       Impact factor: 4.575

7.  Flaxseed reduces epithelial proliferation but does not affect basal cells in induced benign prostatic hyperplasia in rats.

Authors:  Ilma Cely de Amorim Ribeiro; Carlos Alberto Soares da Costa; Vivian Alves Pereira da Silva; Lanna Beatriz Neves Silva Côrrea; Gilson Teles Boaventura; Mauricio Alves Chagas
Journal:  Eur J Nutr       Date:  2016-02-08       Impact factor: 5.614

8.  Inflammatory Mechanisms Associated with Prostatic Inflammation and Lower Urinary Tract Symptoms.

Authors:  Jennifer L St Sauver; Steven J Jacobsen
Journal:  Curr Prostate Rep       Date:  2008-05-01

Review 9.  Aging of the progenitor cells that initiate prostate cancer.

Authors:  Jack Freeland; Preston D Crowell; Jenna M Giafaglione; Paul C Boutros; Andrew S Goldstein
Journal:  Cancer Lett       Date:  2021-05-28       Impact factor: 8.679

10.  Pomegranate Extracts in the Management of Men's Urologic Health: Scientific Rationale and Preclinical and Clinical Data.

Authors:  Nils Kroeger; Kroeger N; A S Belldegrun; Belldegrun A S; A J Pantuck; Pantuck A J
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-26       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.